Related references
Note: Only part of the references are listed.Effects of functional genetic polymorphisms in the CYP19A1 gene on prostate cancer risk and survival
Sohei Kanda et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Maintaining and reprogramming genomic androgen receptor activity in prostate cancer
Ian G. Mills
NATURE REVIEWS CANCER (2014)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Integrative Genomic Analyses Reveal an Androgen-Driven Somatic Alteration Landscape in Early-Onset Prostate Cancer
Joachim Weischenfeldt et al.
CANCER CELL (2013)
The Androgen Receptor Induces a Distinct Transcriptional Program in Castration-Resistant Prostate Cancer in Man
Naomi L. Sharma et al.
CANCER CELL (2013)
ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients
Esther Baena et al.
GENES & DEVELOPMENT (2013)
Low systemic testosterone levels induce androgen maintenance in benign rat prostate tissue
Ye Zhou et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2013)
Risks and benefits of testosterone therapy in older men
Matthew Spitzer et al.
NATURE REVIEWS ENDOCRINOLOGY (2013)
Preoperative therapy for localized prostate cancer: A comprehensive overview
Jensen Hu et al.
MATURITAS (2013)
Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc Upregulation
Lina Gao et al.
PLOS ONE (2013)
EZH2, an epigenetic driver of prostate cancer
Yeqing Angela Yang et al.
PROTEIN & CELL (2013)
Adult Murine Prostate Basal and Luminal Cells Are Self-Sustained Lineages that Can Both Serve as Targets for Prostate Cancer Initiation
Nahyun Choi et al.
CANCER CELL (2012)
Cooperation between Polycomb and androgen receptor during oncogenic transformation
Jonathan C. Zhao et al.
GENOME RESEARCH (2012)
A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease
Vanessa C. Thompson et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Androgen Receptor Serine 81 Phosphorylation Mediates Chromatin Binding and Transcriptional Activation
Shaoyong Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Impact of Male Hormonal Contraception on Prostate Androgens and Androgen Action in Healthy Men: A Randomized, Controlled Trial
Elahe A. Mostaghel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Suppressor role of androgen receptor in proliferation of prostate basal epithelial and progenitor cells
Soo Ok Lee et al.
JOURNAL OF ENDOCRINOLOGY (2012)
Regulation of the androgen receptor by post-translational modifications
Kelly Coffey et al.
JOURNAL OF ENDOCRINOLOGY (2012)
Post-translational modification of the androgen receptor
Daniel Gioeli et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer
A. Urbanucci et al.
ONCOGENE (2012)
AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression
Y. Li et al.
ONCOGENE (2012)
Altered prostate epithelial development in mice lacking the androgen receptor in stromal fibroblasts
Shengqiang Yu et al.
PROSTATE (2012)
EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent
Kexin Xu et al.
SCIENCE (2012)
Targeting the Androgen Receptor
Terence W. Friedlander et al.
UROLOGIC CLINICS OF NORTH AMERICA (2012)
Cell Autonomous Role of PTEN in Regulating Castration-Resistant Prostate Cancer Growth
David J. Mulholland et al.
CANCER CELL (2011)
Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer
Brett S. Carver et al.
CANCER CELL (2011)
Primary Intermittent Androgen Deprivation As Initial Therapy for Men with Newly Diagnosed Prostate Cancer
Mark C. Scholz et al.
CLINICAL GENITOURINARY CANCER (2011)
Androgen Receptor Cofactors in Prostate Cancer: Potential Therapeutic Targets of Castration-Resistant Prostate Cancer
Masaki Shiota et al.
CURRENT CANCER DRUG TARGETS (2011)
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
Charles E. Massie et al.
EMBO JOURNAL (2011)
Intratumoral androgen biosynthesis in prostate cancer pathogenesis and response to therapy
Changmeng Cai et al.
ENDOCRINE-RELATED CANCER (2011)
Alternatively spliced androgen receptor variants
Scott M. Dehm et al.
ENDOCRINE-RELATED CANCER (2011)
New Hormonal Therapies for Castration-Resistant Prostate Cancer
Elahe A. Mostaghel et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2011)
SLCO2B1 and SLCO1B3 May Determine Time to Progression for Patients Receiving Androgen Deprivation Therapy for Prostate Cancer
Ming Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Minireview: Alternative Activation Pathways for the Androgen Receptor in Prostate Cancer
Kristin R. Lamont et al.
MOLECULAR ENDOCRINOLOGY (2011)
Revisiting the concept of cancer stem cells in prostate cancer
Z. A. Wang et al.
ONCOGENE (2011)
Role of autonomous androgen receptor signaling in prostate cancer initiation is dichotomous and depends on the oncogenic signal
Sanaz Memarzadeh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model
Steffen E. Eikenberry et al.
BIOLOGY DIRECT (2010)
An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression
Jindan Yu et al.
CANCER CELL (2010)
Polycomb Group Proteins: Multi-Faceted Regulators of Somatic Stem Cells and Cancer
Martin Sauvageau et al.
CELL STEM CELL (2010)
Stem cells in prostate cancer: treating the root of the problem
Renea A. Taylor et al.
ENDOCRINE-RELATED CANCER (2010)
Genome-wide analysis of androgen receptor binding and gene regulation in two CWR22-derived prostate cancer cell lines
Honglin Chen et al.
ENDOCRINE-RELATED CANCER (2010)
Molecular genetics of prostate cancer: new prospects for old challenges
Michael M. Shen et al.
GENES & DEVELOPMENT (2010)
A Large Study of Androgen Receptor Germline Variants and Their Relation to Sex Hormone Levels and Prostate Cancer Risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium
Sara Lindstroem et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Androgen Receptor CAG Repeat Length and Association With Prostate Cancer Risk: Results From the Prostate Cancer Prevention Trial
Douglas K. Price et al.
JOURNAL OF UROLOGY (2010)
Identification of a Cell of Origin for Human Prostate Cancer
Andrew S. Goldstein et al.
SCIENCE (2010)
Oxidative stress in prostate cancer
Lakshmipathi Khandrika et al.
CANCER LETTERS (2009)
Induction of Prostatic Intraepithelial Neoplasia and Modulation of Androgen Receptor by ETS Variant 1/ETS-Related Protein 81
Sook Shin et al.
CANCER RESEARCH (2009)
Conserved Gene Expression Programs Integrate Mammalian Prostate Development and Tumorigenesis
Colin Pritchard et al.
CANCER RESEARCH (2009)
Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
Qianben Wang et al.
CELL (2009)
Anti-inflammatory drugs, antioxidants, and prostate cancer prevention
Aditya Bardia et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
A luminal epithelial stem cell that is a cell of origin for prostate cancer
Xi Wang et al.
NATURE (2009)
Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis
Jennifer C. King et al.
NATURE GENETICS (2009)
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
Brett S. Carver et al.
NATURE GENETICS (2009)
Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family
Jianming Xu et al.
NATURE REVIEWS CANCER (2009)
Inflammation, infection, and prostate cancer
Eric A. Klein et al.
CURRENT OPINION IN UROLOGY (2008)
Prostate inflammation and its potential impact on prostate cancer: A current review
Jessica Haverkamp et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Endogenous sex hormones and prostate cancer: A collaborative analysis of 18 prospective studies
Andrew W. Roddam et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer
E. M. Schaeffer et al.
ONCOGENE (2008)
A causal role for ERG in neoplastic transformation of prostate epithelium
Olga Klezovitch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Recurrent gene fusions in prostate cancer
Chandan Kumar-Sinha et al.
NATURE REVIEWS CANCER (2008)
CYP17 genetic variation and risk of breast and prostate cancer from the national Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)
Veronica Wendy Setiawan et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
TMPRSS2-ETS fusion prostate cancer: Biological and clinical implications
Francesca Demichelis et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Prolonged exposure to reduced levels of androgen accelerates prostate cancer progression in Nkx3.1; Pten mutant mice
Whitney Banach-Petrosky et al.
CANCER RESEARCH (2007)
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
Scott A. Tomlins et al.
NATURE (2007)
Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor
Chun-Te Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Relative copy number gain of MYC in diagnostic needle biopsies is an independent prognostic factor for prostate cancer patients
Franclim R. Ribeiro et al.
EUROPEAN UROLOGY (2007)
Expression profiling of the mouse prostate after castration and hormone replacement: implication of H-cadherin in prostate tumorigenesis
Xi-De Wang et al.
DIFFERENTIATION (2007)
Bicalutamide (Casodex) 150 mg plus standard care in early non-metastatic prostate cancer:: results from Early Prostate Cancer Trial 24 at a median 7 years' follow-up
M. Wirth et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2007)
Integrative molecular concept modeling of prostate cancer progression
Scott A. Tomlins et al.
NATURE GENETICS (2007)
Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer
Irina U. Agoulnik et al.
CANCER RESEARCH (2006)
Persistent intraprostatic androgen concentrations after medical castration in healthy men
Stephanie T. Page et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Impact of IGF-I and CYP19 gene polymorphisms on the survival of patients with metastatic prostate cancer
N Tsuchiya et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer
DG McLeod et al.
BJU INTERNATIONAL (2006)
PTEN and GSK3 beta: Key regulators of progression to androgen- independent prostate cancer
DJ Mulholland et al.
ONCOGENE (2006)
Genetic variation in the HSD17B1 gene and risk of prostate cancer
P Kraft et al.
PLOS GENETICS (2005)
The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription
MK Jang et al.
MOLECULAR CELL (2005)
Testosterone as a predictor of pathological stage in clinically localized prostate cancer
G Isom-Batz et al.
JOURNAL OF UROLOGY (2005)
Pretreatment serum testosterone level as a predictive factor of pathological stage in localized prostate cancer patients treated with radical prostatectomy
T Imamoto et al.
EUROPEAN UROLOGY (2005)
Mutation of the androgen receptor causes oncogenic transformation of the prostate
GZ Han et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Implementation of the prostate cancer prevention trial (PCPT)
PJ Goodman et al.
CONTROLLED CLINICAL TRIALS (2004)
Hypermethylation of CpG islands in primary and metastatic human prostate cancer
S Yegnasubramanian et al.
CANCER RESEARCH (2004)
High levels of circulating testosterone are not associated with increased prostate cancer risk: A pooled prospective study
P Stattin et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Chemoprevention of prostate cancer in men at high risk: Rationale and design of the reduction by dutasteride of prostate cancer events (reduce) trial
G Andriole et al.
JOURNAL OF UROLOGY (2004)
Identification and validation of novel androgen-regulated genes in prostate cancer
AM Velasco et al.
ENDOCRINOLOGY (2004)
Mechanisms of disease: Prostate cancer
WG Nelson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Androgen receptor mutations in androgen-in dependent prostate cancer: Cancer and Leukemia Group B Study 9663
ME Taplin et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Is the Achilles' heel for prostate cancer therapy a gain of function in androgen receptor signaling?
IV Litvinov et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy
JC Massengill et al.
JOURNAL OF UROLOGY (2003)
Hormonal, cellular, and molecular control of prostatic development
PC Marker et al.
DEVELOPMENTAL BIOLOGY (2003)
Androgenic regulation of oxidative stress in the rat prostate - Involvement of NAD(P)H oxidases and antioxidant defense machinery during prostatic involution and regrowth
NNC Tam et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells
T Ueda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The program of androgen-responsive genes in neoplastic prostate epithelium
PS Nelson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Androgen receptor as a target in androgen-independent prostate cancer
SP Balk
UROLOGY (2002)
Cell differentiation lineage in the prostate
YZ Wang et al.
DIFFERENTIATION (2001)
The development of androgen-independent prostate cancer
BJ Feldman et al.
NATURE REVIEWS CANCER (2001)
Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium
M Stanbrough et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Linkage of prostate cancer susceptibility loci to chromosome 1
JF Xu et al.
HUMAN GENETICS (2001)
Paracrine regulation of apoptosis by steroid hormones in the male and female reproductive system
T Kurita et al.
CELL DEATH AND DIFFERENTIATION (2001)
Treatment of localized prostate cancer with intermittent triple androgen blockade: Preliminary results in 110 consecutive patients
RL Leibowitz et al.
ONCOLOGIST (2001)
Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor
XY Zhao et al.
NATURE MEDICINE (2000)
Share Paper
